Pricing
  1. US-listed companies
  2. BIOLASE, INC
  3. Financials
  4. Cash from operations

BIOLASE, INC【BIOLQ】

Market cap
$36.6
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 2023-14-47.39%
Dec 31, 2022-27+60.38%
Dec 31, 2021-17+30.60%
Dec 31, 2020-13+0.38%
Dec 31, 2019-13-9.90%
Dec 31, 2018-14-23.16%
Dec 31, 2017-18+72.93%
Dec 31, 2016-11-40.09%
Dec 31, 2015-18+9.70%
Dec 31, 2014-16+74.28%
Dec 31, 2013-9+458.65%
Dec 31, 2012-2-87.51%
Dec 31, 2011-13

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)